Main findings – Tendency toward thrombosis and fibrin degeneration
The pathological findings in these two cases were overall of a mild degree and involved the maternal more than the fetal components of the placenta. The maternal changes in P2 were more intense than P1. One remarkable finding was the extent of subchorionic thrombosis and fibrin deposition of P2. This lesion is nonspecific and generally assumed to be the result of stasis of maternal blood in the subchorionic space, which then leads to thrombosis, while massive subchorionic thrombohematomas have been related to hypercoagulability in the maternal circulation [7]. As no known thrombotic risk factors were recorded in either case, it may be suggested that the extensive subchorionic thrombosis and basal thrombi observed in P2, and the decidual vascular thrombosis in P1, may reflect a COVID-19-related tendency toward coagulopathy [8]. Elevations in fibrinogen and fibrin degradation products (D-dimers) [8] and increased formation of fibrin in the lungs [9] have also been observed in patients with COVID-19; this tendency toward fibrin formation is likely to account for the extensive subchorionic and supradecidual fibrin, as well as the patchy intervillous fibrin deposition and degradation seen in our placenta cases. Increased intervillous fibrin deposition in relation to COVID-19 has also been observed by Shanes et al. [4] and Baergen and Heller [5] in PCR-negative third trimester placentas. Moreover, this finding has been described in a small series of placentas delivered from pregnant women with severe acute respiratory syndrome caused by the SARS-COV virus during the 2003 epidemic [10]. In general, intervillous or perivillous fibrin deposition is a nonspecific finding, commonly encountered in various patterns of placental pathology, and often related to increased apoptosis or other damage of the perivillous trophoblast. Prominent shedding of the perivillous syncytiotrophoblast noted in our cases would support this notion, while prominent degradation of intervillous fibrin appears likely related to COVID-19.
Maternal vascular malperfusion (MVM)
Evidence of MVM included a diffuse increase in syncytial knotting and microinfarction in P1, while decidual arteriopathy was not seen in either case. MVM has also been observed in the case series reported by Shanes et al. [4] and in the case of a 32w-placenta abruption reported by Kuhrt et al. [11].
Fetal vascular malperfusion (FVM)
Concerning the fetal vasculature, frank fetal vascular malperfusion with mural thrombi in larger fetal vessels and/or focal avascular villi was seen in ten placentas in the study by Baergen and Heller [5] and in five placentas in the series presented by Shanes et al. [4]. We observed incipient mural thrombus formation in the fetal vessels of P1, however, a disorder in glucose metabolism as an underlying contributory factor could not be ruled out in this case of fetal macrosomia. On the other hand, the intraluminal inflammatory aggregates in the umbilical vein and stem villous vessels also reflected an incipient reaction and could not be interpreted as an established fetal inflammatory response, as in the case of second trimester miscarriage with funisitis [1]. These observations are in alignment with the short interval between the onset of symptoms and delivery, but underscore the potential harmful effects of COVID-19 in cases of early-onset infection during pregnancy. The vacuolated endothelium observed in the umbilical vessels of our cases might possibly be related to the endotheliotropic nature of SARS-COV-2 virus.
Maternal inflammation
Maternal decidual inflammatory changes have not been reported to date in COVID-19 placentas. Inflammatory exudates with lymphomononuclear cells consisting of T-helper and cytotoxic lymphocytes, monocytes, macrophages, and some plasmacytes were seen in both cases in the maternal decidua, and, to a milder degree, in the subchorionic space of maternal blood. Plasmacytes, responsible for antibody formation, have been related to intrauterine transplacental viral infections, such as Cytomegalovirus and others; in our COVID-19 cases they were restricted to the maternal decidua and overlying intervillous blood space, while not being detected in the chorionic villi. Monocytes and macrophages on the other hand appear to characterize the inflammatory reaction triggered by SARS-COV-2 [12]. Exudates with a predominantly lymphocytic inflammation and multinucleated giant cells have been described in the lungs of autopsied COVID-19 patients [13]. The presence of some highly vacuolated multinuclear syncytial cells seen in the maternal decidua of our placentas is of unknown significance and may be unrelated to COVID-19.
With regard to amniotic sac infection, there was no evidence of established histologic chorioamnionitis, although the presence of some clusters of monocytes in the chorionic membranes and underlying decidua capsularis may suggest an incipient maternal infiltrate of the free membranes, blood-borne or spread by direct extension from the decidua basalis. No evidence of frank intervillositis or villitis was seen in our two cases.
Conclusions
Placental pathology was present even in mild disease of presumably very short duration at term pregnancy. The observed changes mainly involved the maternal tissues and blood-occupying space, and appeared related to, though not pathognomonic of COVID-19. The decidual inflammatory exudates, described for the first time in COVID-19 placentas, and the tendency toward thrombosis, fibrin production and degradation, suggest the systemic nature of COVID-19, while on the other hand, fetoplacental vascular changes and endothelial vacuolation associated with mild neonatal morbidity, may suggest a possible transplacental impact on the fetus, to be further investigated. The impact of long-term gestational COVID-19, with SARS-COV-2 infection occurring early in pregnancy remains a challenge to be confronted in the immediate future.